Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion type Assertion NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_head.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion description "[In the current study, we examined a panel of serially passaged glioblastoma xenografts, in the context of an intracranial tumor therapy response model, to identify associations between glioblastoma molecular characteristics and tumor sensitivity to the epidermal growth factor receptor (EGFR) kinase inhibitor erlotinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_provenance.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion evidence source_evidence_literature NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_provenance.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion SIO_000772 17363510 NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_provenance.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion wasDerivedFrom befree-20150227 NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_provenance.
- NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_assertion wasGeneratedBy ECO_0000203 NP370521.RAMhD79c3lQ-KY7fPrDKkzqpWbdWN6JqjTWd-D6eT_upo130_provenance.